CME/CE
Episodes 113-128 of 139
Lale Tokgözoğlu, MD
Fabrice Martens
Roxana Mehran, MD
- MinuteCE®
New insights on CETP inhibition from genetic research and clinical trials
1.00 program creditProf. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Roxana Mehran, MD
Carolyn Ho, MD
Antonis Pantazis, MD
Antonis Pantazis, MD
Pablo García-Pavía, MD, PhD
Carolyn Ho, MD
Pablo García-Pavía, MD, PhD
Richard Hobbs, MD
Lale Tokgözoğlu, MD
- MinuteCE®
Integrating icosapent ethyl in preventive strategies: Practical guidance
1.00 program creditVictor Aboyans, MD, PhD
- MinuteCE®
New paradigms in the prevention of ASCVD: The role of EPA and triglycerides
1.00 credit 3 episodesRichard Hobbs, MD
Lale Tokgözoğlu, MD
Victor Aboyans, MD, PhD
- MinuteCE®
Practical experience and model for optimizing RAASi-based therapy in HF
1.00 program creditAaron Wong, MD
Mikhail Kosiborod, MD
